A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

NCT06123663 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus

Interventions

BIOLOGICAL: TTVA
BIOLOGICAL: TT

Sponsor

CanSino Biologics Inc.